US Stock MarketDetailed Quotes

XLO Xilio Therapeutics

Watchlist

0.917
-0.133-12.64%

Close May 28 16:00 ET

33.86MMarket Cap-356P/E (TTM)

Xilio Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-29.70%16.54M

-11.24%79.13M

-21.74%18.13M

-14.08%17.36M

-18.07%20.12M

10.85%23.53M

18.80%89.15M

18.46%23.17M

26.60%20.21M

6.72%24.55M

Selling and administrative expenses

-16.98%6.14M

-9.85%27M

-21.74%6.39M

-11.97%6.31M

-16.95%6.9M

17.31%7.4M

25.54%29.95M

-0.41%8.17M

30.54%7.17M

57.85%8.31M

-General and administrative expense

-16.98%6.14M

-9.85%27M

-21.74%6.39M

-11.97%6.31M

-16.95%6.9M

17.31%7.4M

25.54%29.95M

-0.41%8.17M

30.54%7.17M

57.85%8.31M

Research and development costs

-35.53%10.4M

-11.93%52.14M

-21.74%11.74M

-15.24%11.05M

-18.64%13.22M

8.12%16.13M

15.65%59.2M

32.11%15M

24.53%13.04M

-8.45%16.25M

Operating profit

29.70%-16.54M

11.24%-79.13M

21.74%-18.13M

14.08%-17.36M

18.07%-20.12M

-10.85%-23.53M

-18.80%-89.15M

-18.46%-23.17M

-26.60%-20.21M

-6.72%-24.55M

Net non-operating interest income expense

Other net income (expense)

-175.45%-664K

194.39%2.73M

-32.24%475K

47.36%613K

1,347.54%761K

782.17%880K

222.62%927K

583.45%701K

243.45%416K

64.94%-61K

Special income (charges)

---948K

----

--0

----

-Less：Restructuring and merger&acquisition

--948K

----

--0

----

Other non- operating income (expenses)

-67.73%284K

194.39%2.73M

-32.24%475K

47.36%613K

1,347.54%761K

782.17%880K

222.62%927K

583.45%701K

243.45%416K

64.94%-61K

Income before tax

24.04%-17.2M

13.40%-76.4M

21.41%-17.66M

15.37%-16.75M

21.36%-19.36M

-6.06%-22.65M

-16.39%-88.22M

-14.03%-22.47M

-21.78%-19.79M

-6.18%-24.61M

Income tax

Net income

24.04%-17.2M

13.40%-76.4M

21.41%-17.66M

15.37%-16.75M

21.36%-19.36M

-6.06%-22.65M

-16.39%-88.22M

-14.03%-22.47M

-21.78%-19.79M

-6.18%-24.61M

Net income continuous Operations

24.04%-17.2M

13.40%-76.4M

21.41%-17.66M

15.37%-16.75M

21.36%-19.36M

-6.06%-22.65M

-16.39%-88.22M

-14.03%-22.47M

-21.78%-19.79M

-6.18%-24.61M

Minority interest income

Net income attributable to the parent company

24.04%-17.2M

13.40%-76.4M

21.41%-17.66M

15.37%-16.75M

21.36%-19.36M

-6.06%-22.65M

-16.39%-88.22M

-14.03%-22.47M

-21.78%-19.79M

-6.18%-24.61M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

24.04%-17.2M

13.40%-76.4M

21.41%-17.66M

15.37%-16.75M

21.36%-19.36M

-6.06%-22.65M

-16.39%-88.22M

-14.03%-22.47M

-21.78%-19.79M

-6.18%-24.61M

Basic earnings per share

25.30%-0.62

13.66%-2.78

21.95%-0.64

15.28%-0.61

22.22%-0.7

-6.41%-0.83

76.18%-3.22

16.33%-0.82

-18.14%-0.72

-3.53%-0.9

Diluted earnings per share

25.30%-0.62

13.66%-2.78

21.95%-0.64

15.28%-0.61

22.22%-0.7

-6.41%-0.83

76.18%-3.22

16.33%-0.82

-18.14%-0.72

-3.53%-0.9

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-29.70%16.54M	-11.24%79.13M	-21.74%18.13M	-14.08%17.36M	-18.07%20.12M	10.85%23.53M	18.80%89.15M	18.46%23.17M	26.60%20.21M	6.72%24.55M
Selling and administrative expenses	-16.98%6.14M	-9.85%27M	-21.74%6.39M	-11.97%6.31M	-16.95%6.9M	17.31%7.4M	25.54%29.95M	-0.41%8.17M	30.54%7.17M	57.85%8.31M
-General and administrative expense	-16.98%6.14M	-9.85%27M	-21.74%6.39M	-11.97%6.31M	-16.95%6.9M	17.31%7.4M	25.54%29.95M	-0.41%8.17M	30.54%7.17M	57.85%8.31M
Research and development costs	-35.53%10.4M	-11.93%52.14M	-21.74%11.74M	-15.24%11.05M	-18.64%13.22M	8.12%16.13M	15.65%59.2M	32.11%15M	24.53%13.04M	-8.45%16.25M
Operating profit	29.70%-16.54M	11.24%-79.13M	21.74%-18.13M	14.08%-17.36M	18.07%-20.12M	-10.85%-23.53M	-18.80%-89.15M	-18.46%-23.17M	-26.60%-20.21M	-6.72%-24.55M
Net non-operating interest income expense
Other net income (expense)	-175.45%-664K	194.39%2.73M	-32.24%475K	47.36%613K	1,347.54%761K	782.17%880K	222.62%927K	583.45%701K	243.45%416K	64.94%-61K
Special income (charges)	---948K	----	----	----	----	--0	----	----	----	----
-Less：Restructuring and merger&acquisition	--948K	----	----	----	----	--0	----	----	----	----
Other non- operating income (expenses)	-67.73%284K	194.39%2.73M	-32.24%475K	47.36%613K	1,347.54%761K	782.17%880K	222.62%927K	583.45%701K	243.45%416K	64.94%-61K
Income before tax	24.04%-17.2M	13.40%-76.4M	21.41%-17.66M	15.37%-16.75M	21.36%-19.36M	-6.06%-22.65M	-16.39%-88.22M	-14.03%-22.47M	-21.78%-19.79M	-6.18%-24.61M
Income tax
Net income	24.04%-17.2M	13.40%-76.4M	21.41%-17.66M	15.37%-16.75M	21.36%-19.36M	-6.06%-22.65M	-16.39%-88.22M	-14.03%-22.47M	-21.78%-19.79M	-6.18%-24.61M
Net income continuous Operations	24.04%-17.2M	13.40%-76.4M	21.41%-17.66M	15.37%-16.75M	21.36%-19.36M	-6.06%-22.65M	-16.39%-88.22M	-14.03%-22.47M	-21.78%-19.79M	-6.18%-24.61M
Minority interest income
Net income attributable to the parent company	24.04%-17.2M	13.40%-76.4M	21.41%-17.66M	15.37%-16.75M	21.36%-19.36M	-6.06%-22.65M	-16.39%-88.22M	-14.03%-22.47M	-21.78%-19.79M	-6.18%-24.61M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	24.04%-17.2M	13.40%-76.4M	21.41%-17.66M	15.37%-16.75M	21.36%-19.36M	-6.06%-22.65M	-16.39%-88.22M	-14.03%-22.47M	-21.78%-19.79M	-6.18%-24.61M
Basic earnings per share	25.30%-0.62	13.66%-2.78	21.95%-0.64	15.28%-0.61	22.22%-0.7	-6.41%-0.83	76.18%-3.22	16.33%-0.82	-18.14%-0.72	-3.53%-0.9
Diluted earnings per share	25.30%-0.62	13.66%-2.78	21.95%-0.64	15.28%-0.61	22.22%-0.7	-6.41%-0.83	76.18%-3.22	16.33%-0.82	-18.14%-0.72	-3.53%-0.9
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall